In another study, after adjustment for gestational age, supplemental oxygen therapy and gender, the VEGF −460TT/+405CC haplotype was associated with an increased likelihood and the −460TT/+405GG haplotype with a decreased likelihood of requiring ROP treatment (16). The gene discussed is VEGFA; the disease is retinopathy of prematurity.